tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Astera Labs initiated with an Outperform at BNP Paribas Exane

BNP Paribas Exane initiated coverage of Astera Labs (ALAB) with an Outperform rating and $225 price target which represents over 50% upside. The stock has declined 40% from the peak on investor concerns over the market acceptance of UALink, which creates an attractive entry point, the analyst tells investors in a research note. BNP thinks Amazon’s next generations of Trainium server systems could drive significant revenue growth opportunities for Astera over the next three years.

TipRanks Black Friday Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1